Navigation Links
JMP from JMP

ProductsJMP from JMP
Company JMP
Item JMP
Price Inquire
Description JMP 6 delivers enhanced statistics and statistical interpretation to researchers, product innovators, and quality improvement managers. As an accepted organizational standard for analytics worldwide, JMP 6 simplifies statistics for novice users and includes the comprehensive analytics needed by experts. It offers a powerful JMP Scripting Language (JSL), a menu generator, and journaling tools that capture analytic sequences and make them available for replay throughout an organization.
Info JMPJMP
SAS Campus Drive
Cary, NC 27513
Customer Service: (919) 677-8000
Fax Number: (919) 677-4444
Web Site: http://www.jmp.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
2. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
3. Custom Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
4. Goat Anti-Pyruvate Kinase Polyclonal Antibody, Unconjugated from AbD Serotec
5. T4 Polynucleotide Kinase from EPICENTRE Biotechnologies
6. Mouse Anti-Rat L-Pyruvate Kinase Monoclonal Antibody, Unconjugated, Clone AD12 from ScheBo Biotech AG
7. Mouse Anti-Guanylate Kinase Monoclonal Antibody, Unconjugated, Clone 28 from BD Biosciences Pharmingen
8. T4 Polynucleotide Kinase from Promega
9. Rabbit Anti-Human Janus Kinase 2 (JAK2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
10. Anti-CaMKII (Calmodulin-dependent Protein Kinase II) Monoclonal Antibody, Unconjugated, Clone 6G9 (2) from CHEMICON
11. Universal Kinase / Phosphatase Fluorescence superquenching Assay Kit, TruLight™ from Calbiochem
TAG: JMP from JMP
T7 RNA Polymerase from Invitrogen
T7 RNA polymerase from Chimerx
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
RNase H from Roche Applied Science
Biology Products:
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
(Date:12/2/2009)PHILADELPHIA Exposure to secondhand smoke for a prolonged period of time and in high quantity may increase the risk of breast cancer, even in women who never smoked cigarettes themselves. , "The qu
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Gen Probe to Webcast Two Upcoming Investor Presentations 5888 1Gen Probe to Webcast Two Upcoming Investor Presentations 5888 2Patients More Likely to Die While in ICU in U S Than in England 60428 1Patients More Likely to Die While in ICU in U S Than in England 60428 2
...ommonwealth University Massey Cancer Center have f...ement of human breast cancer cells toward epiderma...nal of Biological Chemistry, researchers showed th... role in breast cancer progression, stimulates sph...nzymes that forms the potent lipid mediator, sphin...
...ar subtleties of a strain of mice engineered to ag...ion of genetic mutations prompts a cascade of prog... process. , Writing today (July 15, 2005) in the j...sity of Wisconsin-Madison geneticist Tomas A. Prol... normal mice that peel away some of the root secre...
...global health threat. Although more than 3 billion...o fight tuberculosis, the ability of the BCG vacci...ficacy against newly emerging isolates. , In a stu...nt publication of the September 1 issue of the Jou...d colleagues from the Max Planck Institute devise ...
Other Biology News:Elderly mice yield clues to the process of growing old 2Elderly mice yield clues to the process of growing old 3
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3